Results 1 to 10 of about 195,219 (266)

SIRT1: potential target in glucocorticoid-resistant diseases [PDF]

open access: yesFrontiers in Immunology
Glucocorticoid resistance is a challenging problem in clinical practice. Increasing glucocorticoid sensitivity and reducing resistance are important in the management of certain diseases.
Jun Xie, Siyi Che, Jiao Liu, Xiaoru Long
doaj   +2 more sources

Burden of Glucocorticoid Use and Risk of Toxicities Among Patients with Immunoglobulin-G4-Related Disease: A Retrospective US-Based Claims Study [PDF]

open access: yesRheumatology and Therapy
Introduction Glucocorticoids are commonly used to treat immunoglobulin G4-related disease (IgG4-RD), but there is limited real-world evidence describing glucocorticoid-related toxicities in this population.
Zachary S. Wallace   +7 more
doaj   +2 more sources

Hypoglycaemia in adrenal insufficiency

open access: yesFrontiers in Endocrinology, 2023
Adrenal insufficiency encompasses a group of congenital and acquired disorders that lead to inadequate steroid production by the adrenal glands, mainly glucocorticoids, mineralocorticoids and androgens.
Shien Chen Lee   +6 more
doaj   +1 more source

The Negative Effect of Protein Phosphatase Z1 Deletion on the Oxidative Stress Tolerance of Candida albicans Is Synergistic with Betamethasone Exposure

open access: yesJournal of Fungi, 2021
The glucocorticoid betamethasone (BM) has potent anti-inflammatory and immunosuppressive effects; however, it increases the susceptibility of patients to superficial Candida infections.
Ágnes Jakab   +12 more
doaj   +1 more source

Tart Cherry (Fruit of Prunus cerasus) Concentrated Powder (TCcp) Ameliorates Glucocorticoid-Induced Muscular Atrophy in Mice

open access: yesMedicina, 2021
Background and Objectives: The present study investigated the beneficial effects of tart cherry (fruit of Prunus cerasus) concentrated powder (TCcp) on glucocorticoid (GLU)-induced catabolic muscular atrophy in the skeletal muscle of mice.
Sae-Kwang Ku   +5 more
doaj   +1 more source

Case Report: Real NPSLE? A patient with systemic sclerosis overlapping systemic lupus erythematosus presenting as epilepsy

open access: yesFrontiers in Immunology, 2023
Neuropsychiatric systemic lupus erythematosus (NPSLE) is the diagnosis that rheumatologists most often need to consider when a patient with lupus presents with neurologic symptoms.
Jialin Zhang   +4 more
doaj   +1 more source

Glucocorticoids in rheumatoid arthritis: current status and future studies

open access: yesRMD Open, 2020
Since their first use for treating rheumatoid arthritis (RA) in the late 1940s, glucocorticoids (GCs) have been representing a substantial part of the therapeutic arsenal for RA.
Frank Buttgereit   +2 more
doaj   +1 more source

Expression of long noncoding RNA Xist is induced by glucocorticoids

open access: yesFrontiers in Endocrinology, 2022
Glucocorticoids (GCs) are potent anti-inflammatory and immunosuppressive agents. However, their clinical usage is limited by severe multisystemic side effects.
Yun Su   +10 more
doaj   +1 more source

Acinetobacter baumannii among Patients Receiving Glucocorticoid Aerosol Therapy during Invasive Mechanical Ventilation, China

open access: yesEmerging Infectious Diseases, 2022
Acinetobacter baumannii is a nosocomial pathogen associated with severe illness and death. Glucocorticoid aerosol is a common inhalation therapy in patients receiving invasive mechanical ventilation.
Wenchao Zhang   +9 more
doaj   +1 more source

Network Meta-Analysis of Different Intravenous Glucocorticoid Regimes for the Treatment of Graves’ Orbitopathy

open access: yesFrontiers in Pharmacology, 2022
Background: Intravenous glucocorticoid (GC) has been proposed to treat moderately severe Graves’ orbitopathy (GO); however, the optimal regime remains debatable.
Jun Jia, Jingjian Dong, Lin Deng
doaj   +1 more source

Home - About - Disclaimer - Privacy